Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma

Liping Zhuang1, Litao Xu1, Peng Wang1

  • 1Department of Integrative Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Collaborative Innovation Center for Cancer Medcine, Shanghai, China.

Oncotarget
|September 4, 2015
PubMed

Insights

Targeting the Na+/K+-ATPase alpha 1 subunit (ATP1A1) shows promise for hepatocellular carcinoma (HCC) treatment. Inhibiting ATP1A1 reduces HCC cell proliferation, migration, and tumorigenicity, offering a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge with limited effective treatments.
  • Understanding the molecular mechanisms driving HCC progression is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the expression patterns of Na+/K+-ATPase (NKA) alpha subunits in human HCC.
  • To evaluate the potential of NKA alpha subunits, particularly ATP1A1, as therapeutic targets for HCC.

Main Methods:

  • Analysis of mRNA expression profiles of NKA alpha subunits in human HCC and adjacent non-tumor tissues.
  • Western blotting to assess ATP1A1 protein levels in HCC samples.
  • In vitro and in vivo experiments involving ATP1A1 knockdown in HCC cell lines (HepG2, MHCC97H, Hep3B).
  • Assessment of cell proliferation, cell-cycle arrest, apoptosis, migration, and reactive oxygen species (ROS) levels.

Main Results:

  • The mRNA and protein expression of the NKA alpha 1 subunit (ATP1A1) were significantly elevated in HCC tissues compared to non-tumor tissues.
  • Knockdown of ATP1A1 suppressed HCC cell proliferation in vitro and tumorigenicity in vivo.
  • ATP1A1 downregulation induced G2/M cell-cycle arrest, apoptosis, and decreased migration in HCC cells.
  • Reduced ATP1A1 expression led to intracellular ROS accumulation, which was mitigated by N-acetyl cysteine.

Conclusions:

  • ATP1A1 is overexpressed in HCC and plays a critical role in tumor growth and progression.
  • Targeting ATP1A1 represents a novel and promising therapeutic strategy for hepatocellular carcinoma.
  • Further investigation into ATP1A1-targeted therapies could lead to improved clinical outcomes for HCC patients.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.9K
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.9K
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
2.6K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K